Approval · Notice of Compliance 8613 · 2007
TYPHERIX: Notice of Compliance 8613
Issued February 23, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8613
- Date
- February 23, 2007
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing facility
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TYPHERIX | Not yet assigned | — |
Medicinal ingredients
- SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE 25 MCG per 0.5ML